Notice: This company has been marked as potentially delisted and may not be actively trading. Intensity Therapeutics, Inc. Common stock (INTS) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesOwnershipShort InterestTrends Institutional Ownership Changes (13F Filings) for Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS)CurrentInstitutional OwnershipPercentage3.74%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$4.74MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$200.83K Get INTS Insider Trade Alerts Want to know when executives and insiders are buying or selling Intensity Therapeutics, Inc. Common stock stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data INTS Institutional Buying and Selling by Quarter Remove Ads Intensity Therapeutics, Inc. Common stock Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/18/2025 GTS Securities LLC19,030$34K0.0%-49.0%0.126% 2/17/2025 Citadel Advisors LLC14,964$26K0.0%N/A0.099% 2/7/2025 Mesirow Financial Investment Management Inc.20,000$35K0.0%-54.7%0.132% 2/3/2025 Sigma Planning Corp54,837$97K0.0%+14.9%0.363% 1/29/2025 Sapient Capital LLC942,841$1.66M0.0%-6.7%6.244% 11/16/2024 Geode Capital Management LLC64,349$246K0.0%+35.1%0.467% 8/12/2024 Blair William & Co. IL37,805$185K0.0%N/A0.276% 4/26/2024 Mesirow Financial Investment Management Inc.44,177$230K0.0%N/A0.322% 4/23/2024 Sapient Capital LLC1,012,069$5.26M0.1%+406.0%7.382% 2/9/2024 Hohimer Wealth Management LLC44,779$384K0.1%-76.0%0.327% 2/6/2024 Sapient Capital LLC200,000$1.71M0.0%N/A1.459% 2/1/2024 Sigma Planning Corp34,443$295K0.0%-28.5%0.251% 1/29/2024 Sapient Capital LLC200,000$1.71M0.1%N/A1.459% 11/21/2023 Hohimer Wealth Management LLC186,464$740K0.2%N/A1.360% 11/6/2023 Sigma Planning Corp48,144$191K0.0%N/A0.352% (Data available from 1/1/2016 forward)Remove Ads INTS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of INTS shares? During the previous two years, the following institutional investors and hedge funds held shares of Intensity Therapeutics, Inc. Common stock shares: Sapient Capital LLC ($1.66M), Hohimer Wealth Management LLC ($384K), Geode Capital Management LLC ($246K), Blair William & Co. IL ($185K), Sigma Planning Corp ($97K), Mesirow Financial Investment Management Inc. ($35K), and GTS Securities LLC ($34K).Learn more on INTS's institutional investors. What percentage of Intensity Therapeutics, Inc. Common stock stock is owned by institutional investors? 3.74% of Intensity Therapeutics, Inc. Common stock stock is owned by institutional investors. Learn more on INTS's institutional investor holdings. Which institutional investors have been buying Intensity Therapeutics, Inc. Common stock stock? The following institutional investors have purchased Intensity Therapeutics, Inc. Common stock stock in the last 24 months: Sapient Capital LLC ($1.21M), Hohimer Wealth Management LLC ($186.46K), Sigma Planning Corp ($55.24K), Mesirow Financial Investment Management Inc. ($44.18K), Blair William & Co. IL ($37.81K), Geode Capital Management LLC ($16.73K), and Citadel Advisors LLC ($14.96K). How much institutional buying is happening at Intensity Therapeutics, Inc. Common stock? Institutional investors have bought a total of 1,567,445 shares in the last 24 months. This purchase volume represents approximately $9.10M in transactions. Which Intensity Therapeutics, Inc. Common stock major shareholders have been selling company stock? The following institutional investors have sold Intensity Therapeutics, Inc. Common stock stock in the last 24 months: Hohimer Wealth Management LLC ($141.69K), Sapient Capital LLC ($67.91K), Mesirow Financial Investment Management Inc. ($24.18K), GTS Securities LLC ($18.26K), and Sigma Planning Corp ($13.70K). How much institutional selling is happening at Intensity Therapeutics, Inc. Common stock? Institutional investors have sold a total of 265,733 shares in the last 24 months. This volume of shares sold represents approximately $1.53M in transactions. Related Companies TIL Institutional Ownership ADAP Institutional Ownership FATE Institutional Ownership STRO Institutional Ownership CHRS Institutional Ownership IVVD Institutional Ownership KYTX Institutional Ownership ELUT Institutional Ownership BDTX Institutional Ownership VXRT Institutional Ownership This page (NASDAQ:INTS) was last updated on 3/13/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intensity Therapeutics, Inc. Common stock Please log in to your account or sign up in order to add this asset to your watchlist. Share Intensity Therapeutics, Inc. Common stock With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
